Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $37.5000 (-6.25%) ($36.0000 - $44.7500) on Sat. Nov. 24, 2012. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 14.36% (three month average) | RSI | 59 | Latest Price | $37.5000(-6.25%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 8.9% a day on average for past five trading days. | Weekly Trend | CAPR advances 11.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting CAPR price | CAPR will decline at least -7.18% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -7.18% (StdDev 14.36%) | Hourly BBV | 0 () | Intraday Trend | -6.3% | | | |
|
5 Day Moving Average | $30.5(22.95%) | 10 Day Moving Average | $26.19(43.18%) | 20 Day Moving Average | $29.42(27.46%) | To recent high | -46.4% | To recent low | 120.6% | Market Cap | $N/A | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |